Medpace Holdings, Inc.·4

Jul 2, 4:04 PM ET

Carley Brian T 4

Research Summary

AI-generated summary

Updated

Medpace (MEDP) Director Brian Carley Converts 36 RSUs to Shares

What Happened

  • Brian T. Carley, a director of Medpace Holdings, had 36 restricted stock units (RSUs) vest and converted them into 36 shares of MEDP common stock on June 30, 2026 (transaction code M — exercise/conversion of a derivative). The filing also shows 36 shares were disposed of the same day at $0.00, which reflects shares withheld rather than a market sale (net new shares to the insider appear to be zero).

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-02 (appears timely).
  • Acquired: 36 shares via conversion of RSUs (derivative exercise).
  • Disposed: 36 shares at $0.00 (share withholding, typically for tax obligations).
  • Shares owned after the transaction: not specified in the filing.
  • Footnotes: F1 explains each RSU converts to one share; F2 notes the RSUs were granted Nov 28, 2025 (143 RSUs total) vesting in four roughly equal installments on 3/31/2026, 6/30/2026, 9/30/2026 and 12/31/2026.

Context

  • This is a routine vesting/conversion of RSUs with simultaneous share withholding to satisfy tax obligations — not an open-market purchase or sale signaling a directional bet. For derivative transactions like this, the insider converts contingent awards into shares; withheld shares are commonly used for taxes rather than indicating a sale.